Lck associates with and is activated by kit in a small cell lung cancer cell line: Inhibition of SCF-mediated growth by the Src family kinase inhibitor PP1

Cancer Research

Volumn 58, Issue 20, 1998, Pages 4660-4666

  Krystal, Geoffrey W ^a,c   DeBerry, Candy S ^b   Linnekin, Diana ^b   Litz, Julie ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN TYROSINE KINASE; STEM CELL FACTOR;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL PROLIFERATION; LEUKEMIA CELL LINE; LUNG SMALL CELL CANCER; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

CARCINOMA, SMALL CELL; ENZYME INHIBITORS; HUMANS; JURKAT CELLS; LUNG NEOPLASMS; LYMPHOCYTE SPECIFIC PROTEIN TYROSINE KINASE P56(LCK); PROTO-ONCOGENE PROTEINS C-KIT; PYRAZOLES; PYRIMIDINES; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; STEM CELL FACTOR;

EID: 0032532096     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Yarden, Y., Kuang, W. J., Yang-Feng, T., Coussens, L., Munemitsu, S., Dull, T. J., Chen, E., Schlessinger, J., Francke, U., and Ullrich, A. Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J., 6: 3341-3351, 1987.
2. Lev, S., Blechman, J. M., Givol, D., and Yarden, Y. Steel factor and c-kit protooncogene: genetic lessons in signal transduction. Crut. Rev. Oncogenesis, 5: 141-168, 1994.
3. Hibi, K., Takahashi, T., Sekido, Y., Ueda, R., Hida, T., Ariyoshi, Y., Takagi, H., and Takahashi, T. Coexpression of the stem cell factor and the c-kit genes in small-cell lung cancer. Oncogene, 6: 2291-2296, 1991.
4. Plummer, H., III, Catlett, J., Leftwich, J., Armstrong, B., Carlson, P., Huff, T., and Krystal, G. c-myc expression correlates with suppression of c-kit protooncogene expression in small cell lung cancer cell lines. Cancer Res., 53: 4337-4342, 1993.
5. Rygaard, K., Nakamura, T., and Spang-Thomsen. M. Expression of the protooncogenes c-met and c-kit and their ligands, hepatocyte growth factor/scatter factor and stem cell factor in SCLC cell lines and xenografts. Br. J. Cancer. 67: 37-46, 1993.
6. Sekido, Y., Takahashi, T., Ueda, R., Takahashi, M., Suzuki, H., Nishida, K., Tsukamoto, T., Hida, T., Shimokata, K., Zsebo, K. M., and Takahashi, T. Recombinant human stem cell factor mediates chemotaxis of small-cell lung cancer cell lines aberrantly expressing the c-kit protooncogene. Cancer Res., 53: 1709-1714, 1993.
7. Krystal, G. W., Carlson, P., and Litz, J. Induction of apoptosis and inhibition of small cell lung cancer growth by the quinoxaline tyrphostins. Cancer Res., 57: 2203-2208, 1997.
8. Krystal, G. W., Hines, S., and Organ, C. Autocrine growth of small cell lung cancer mediated by coexpression of c-kit and stem cell factor. Cancer Res., 56: 370-376, 1996.
9. Mellstrom, K., Bjelfman, C., Hammerling, U., and Pahlman, S. Expression of c-src in cultured human neuroblastoma and small-cell lung carcinoma cell lines correlates with neurocrine differentiation. Mol. Cell. Biol., 7: 4178-4184, 1987.
10. Courtneidge, S. A., Dhand, R., Pilat, D., Twamley, G. M., Waterfield, M. D., and Roussel, M. F. Activation of Src family kinases by colony stimulating factor-1, and their association with its receptor. EMBO J., 12: 943-950, 1993.
11. Kypta, R. M., Goldberg, Y., Ulug, E. T., and Courtneidge, S. A. Association between the PDGF receptor and members of the src family of tyrosine kinases. Cell, 62: 481-492, 1990.
12. Mori, S., Ronnstrand, L., Yokote, K., Engstrom, A., Courtneidge, S. A., Claesson-Welsh, L., and Heldin, C-H. Identification of two juxtamembrane autophosphorylation sites in the PDGF β-receptor; involvement in lhe interaction with Src family tyrosine kinases. EMBO J., 12: 2257-2264, 1993.
13. Roche, S., Koegl, M., Barrone, M. V., Roussel, M. F., and Courtneidge, S. A. DNA synthesis induced by some but not all growth factors requires Src family protein tyrosine kinases. Mol. Cell. Biol., 15: 1102-1109, 1995.
14. c-src. Mol. Cell. Biol., 8: 497-501, 1988.
15. c-src with two major signaling pathways in human breast cancer. Proc. Natl. Acad. Sci. USA, 91: 83-87, 1994.
16. Samuelson, L. E., and Klausner, R. D. Tyrosine kinases and tyrosine-based activation motifs: current research on activation via the T cell antigen receptor. J. Biol. Chem., 267: 24913-24916, 1992.
17. Weiss, A., and Littman, D. R. Signal transduction by lymphocyte antigen receptors. Cell, 76: 263-294, 1994.
18. lck. Nature (Lond.), 357: 161-164, 1992.
19. lck: identification of novel intermolecular association. Science (Washington DC), 252: 1523-1528, 1991.
20. Veillette, A., Foss, F. M., Sausville, E. A., Bolen, J. B., and Rosen, N. Expression of the lck tyrosine kinase gene in human colon carcinoma and other non-lymphoid human tumor cell lines. Oncogene Res., 1: 357-374, 1987.
21. Carmichael J., DeGraf, W. G., Gazdar, A. D., Minna, J. D., and Mitchell, J. B. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res., 47: 936-942, 1987.
22. Hanke, J. H., Gardner, J. P., Dow, R. L., Changelian, P. S., Brissette, W. H., Weringer, E. J., Pollock, B. A., and Connelly, P. A. Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. J. Biol. Chem., 271: 695-701, 1996.
23. Linnekin, D., DeBerry, C. S., and Mou, S. Lyn associates with the juxtamembrane region of c-Kit and is activated by stem cell factor in hematopoietic cell lines and normal progenitors. J. Biol. Chem., 272: 27450-27455, 1997.
24. Gavrieli, Y., Sherman, Y., and Ben-Sassoon, S. A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragments. J. Cell Biol., 119: 493-501, 1992.
25. lck. Nature (Lond.), 338: 257-259, 1989.
26. Nakanishi, Y., Mulshine, J. L., Kasprzyk, P. G., Natale, R. B., Maneckjee, R., Avis, I., Treston, A. M., Gazdar, A. F., Minna, J. D., and Cuttitta, F. Insulin-like growth factor-I can mediate autocrine proliferation of human small cell lung cancer cell lines in vitro. J. Clin. Invest., 82: 354-359, 1988.
27. Carbone, D. P. The biology of lung cancer. Semin. Oncol., 24: 38-401, 1997.
28. Carney, D. N., Gazdar, A. F., Bepler, G., Guccion, J. G., Marangos, P. J., Moody, T. W., Zweig, M. H., and Minna, J. D. Establishment and identification of small cell lung cancer cell lines having classic and variant features. Cancer Res., 45: 2913-2923, 1985.
29. Barone, M. V., and Courtneidge, S. A. Myc but not Fos rescue of PDGF signalling block caused by kinase-inactive Src. Nature (Lond.), 378: 509-512, 1995.
30. Eisenman, R. N., and Cooper, J. A. Beating a path to Myc. Nature (Lond.), 378: 438-439, 1995.
31. Spencer, C. A., and Groudine, M. Control of c-myc regulation in normal and neoplastic cells. Adv. Cancer Res., 56: 1-48, 1991.
32. Krystal, G., Birrer, M., Way, J., Nau, M., Sausville, E., Thompson, C., Minna, J., and Battey, J. Multiple mechanisms for transcriptional regulation of the myc gene family in small-cell lung cancer. Mol. Cell. Biol., 8: 3373-3381, 1988.
33. lck. Proc. Natl. Acad. Sci. USA. 88: 1996-2000, 1991.